newsfilter
← Latest News
GlobeNewswire·

Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference

WAYNE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today